Thursday, January 21, 2016

Alkermes Reports Disappointing Trial Results For Depression Drug

Alkermes said two late-stage studies of its treatment for major depressive disorder didn't meet their primary endpoints, a significant setback for the company, erasing nearly a third of its market value.

from WSJ.com: US Business http://ift.tt/1PGXANo
via IFTTT

No comments:

Post a Comment